Clinical Trials Directory

Trials / Completed

CompletedNCT02540798

Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?

Do Increased Levels of Anxiety Decrease the Reproducibility of Symptoms During Urodynamic Studies in Women?

Status
Completed
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
Sandwell & West Birmingham Hospitals NHS Trust · Academic / Other
Sex
Female
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

This study will look at how pre-test anxiety levels affect the reproducibility of symptoms during routine urodynamic testing in women. Urodynamics is a test that assesses the function of the lower urinary tract, including the bladder.

Detailed description

The results of urodynamic tests often determine treatment for patients, which may include bladder retraining, medication and/or surgery. Thus, it is important for the results of urodynamics to be accurate and representative of the patient's symptoms outside of the clinic. Pre-test anxiety levels in women undergoing urodynamics will be measured using a validated questionnaire HADS (Hospital anxiety and depression scale). The patient, prior to their routine urodynamics test, will fill out this self-administered questionnaire. Reproducibility of patient symptoms will be measured using a non-validated quantitative bladder test assessment. The patient will fill out this self-administered quantitative bladder assessment after their urodynamics test. The pre-test anxiety and symptom reproducibility variables will be correlated against each other to assess whether there is correlation between the two. A Spearman Rho test will be used to assess the strength of the relationship.

Conditions

Timeline

Start date
2015-07-01
Primary completion
2015-11-01
Completion
2016-04-01
First posted
2015-09-04
Last updated
2016-10-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02540798. Inclusion in this directory is not an endorsement.